158 related articles for article (PubMed ID: 34055647)
1. Comparison of Percutaneous Radiofrequency Ablation for Subcapsular and Non-Subcapsular Colorectal Cancer Liver Metastases.
Fan H; Wang X; Qu J; Lu W; Xu S; Wu X; Xia J; Zhang Y; Sun J; Yang X
Front Oncol; 2021; 11():678490. PubMed ID: 34055647
[TBL] [Abstract][Full Text] [Related]
2. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
Wang CZ; Yan GX; Xin H; Liu ZY
World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
[TBL] [Abstract][Full Text] [Related]
4. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival.
Lee HJ; Lee MW; Ahn SH; Cha DI; Ko SE; Kang TW; Song KD; Rhim H
Ultrasonography; 2022 Oct; 41(4):728-739. PubMed ID: 35909318
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety.
Worakitsitisatorn A; Lu DS; Lee MW; Asvadi NH; Moshksar A; Yuen AD; McWilliams J; Raman SS
Eur Radiol; 2020 Mar; 30(3):1813-1821. PubMed ID: 31822975
[TBL] [Abstract][Full Text] [Related]
8. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.
Wang X; Sofocleous CT; Erinjeri JP; Petre EN; Gonen M; Do KG; Brown KT; Covey AM; Brody LA; Alago W; Thornton RH; Kemeny NE; Solomon SB
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):166-75. PubMed ID: 22535243
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
[TBL] [Abstract][Full Text] [Related]
10. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
Odisio BC; Yamashita S; Huang SY; Kopetz SE; Ahrar K; Mizuno T; Conrad C; Aloia TA; Chun YS; Gupta S; Vauthey JN
J Vasc Interv Radiol; 2018 Mar; 29(3):395-403.e1. PubMed ID: 29395898
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.
Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT
J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394
[TBL] [Abstract][Full Text] [Related]
12. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
[TBL] [Abstract][Full Text] [Related]
13. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
[TBL] [Abstract][Full Text] [Related]
14. Intraprocedural Versus Initial Follow-up Minimal Ablative Margin Assessment After Colorectal Liver Metastasis Thermal Ablation: Which One Better Predicts Local Outcomes?
Lin YM; Paolucci I; Albuquerque Marques Silva J; O'Connor CS; Fellman BM; Jones AK; Kuban JD; Huang SY; Metwalli ZA; Brock KK; Odisio BC
Invest Radiol; 2024 Apr; 59(4):314-319. PubMed ID: 37812469
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
16. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous radiofrequency ablation using internally cooled wet electrodes for treatment of colorectal liver metastases.
Yoon HM; Kim JH; Shin YM; Won HJ; Kim PN
Clin Radiol; 2012 Feb; 67(2):122-7. PubMed ID: 21906730
[TBL] [Abstract][Full Text] [Related]
18. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
20. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
Shady W; Petre EN; Vakiani E; Ziv E; Gonen M; Brown KT; Kemeny NE; Solomon SB; Solit DB; Sofocleous CT
Oncotarget; 2017 Sep; 8(39):66117-66127. PubMed ID: 29029497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]